19-18193294-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032683.3(MPV17L2):c.13G>A(p.Gly5Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000719 in 1,543,060 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_032683.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MPV17L2 | NM_032683.3 | c.13G>A | p.Gly5Ser | missense_variant | 1/5 | ENST00000599612.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MPV17L2 | ENST00000599612.3 | c.13G>A | p.Gly5Ser | missense_variant | 1/5 | 1 | NM_032683.3 | P1 | |
MPV17L2 | ENST00000532896.5 | n.63G>A | non_coding_transcript_exon_variant | 1/3 | 2 | ||||
MPV17L2 | ENST00000533807.3 | n.45G>A | non_coding_transcript_exon_variant | 1/4 | 2 | ||||
MPV17L2 | ENST00000534421.1 | n.77G>A | non_coding_transcript_exon_variant | 1/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152242Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000406 AC: 6AN: 147616Hom.: 0 AF XY: 0.0000359 AC XY: 3AN XY: 83476
GnomAD4 exome AF: 0.0000661 AC: 92AN: 1390818Hom.: 0 Cov.: 31 AF XY: 0.0000523 AC XY: 36AN XY: 688890
GnomAD4 genome AF: 0.000125 AC: 19AN: 152242Hom.: 0 Cov.: 33 AF XY: 0.000108 AC XY: 8AN XY: 74376
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 23, 2022 | The c.13G>A (p.G5S) alteration is located in exon 1 (coding exon 1) of the MPV17L2 gene. This alteration results from a G to A substitution at nucleotide position 13, causing the glycine (G) at amino acid position 5 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at